Last updated on February 2019
Chart Review of Repatha in Subjects With Hyperlipidaemia
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Hypercholesterolemia
-
Age: Between 18 - 100 Years
-
Gender: Male or Female
Inclusion Criteria:
Adults (>18 years) Provided informed consent Initiated on Repatha at physician's discretion, after 1st August 2015 Received at least one dose of Repatha
Exclusion Criteria:
Enrolled in an interventional study of PCSK9 inhibitor within 12 weeks prior to initiation of Repatha Received commercially available PCSK9 inhibitor within 12 weeks prior to initiation of Repatha
